Inpalix 3 mg prolonged-release tablets EFG

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Inpalix 3 mg prolonged-release tablets EFG

paliperidone

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, because it could harm them.
• If you experience any side effects, talk to your doctor, pharmacist or nurse, even if they are side effects not listed in this leaflet. See section 4.

Leaflet contents:

1. What Inpalix is and what it is used for
2. What you need to know before taking Inpalix
3. How to take Inpalix
4. Possible side effects
5. How to store Inpalix
6. Contents of the pack and other information

1. What Inpalix is and what it is used for

Paliperidona contains the active substance paliperidone, which belongs to the class of antipsychotic medicines.

Paliperidona is used to treat schizophrenia in adults and adolescents aged 15 years and older.

Schizophrenia is a disorder that causes symptoms including hearing, seeing, or feeling things that do not exist, having false beliefs, excessive distrust, social withdrawal, incoherent speech, and blunted behavior and emotional expression. People with this disorder may also feel depressed, anxious, guilty, or tense.

Paliperidona is also used to treat schizoaffective disorder in adults.

Schizoaffective disorder is a mental condition in which a person experiences several of the symptoms of schizophrenia (listed in the paragraph above) as well as mood disorder symptoms (feelings of euphoria, sadness, agitation, distractibility, insomnia, pressured speech, loss of interest in daily activities, excessive or reduced sleep, excessive or reduced food intake, and recurrent suicidal thoughts).

Paliperidona may help relieve the symptoms of your illness and prevent them from returning.

2. What you need to know before taking Inpalix

Do not take paliperidone

• if you are allergic to paliperidone, risperidone, or any of the other components of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before starting paliperidone.

• Patients with schizoaffective disorder treated with this medicine should be closely monitored for possible changes from manic symptoms to depressive symptoms.

• This medicine has not been studied in elderly patients with dementia. However, elderly patients with dementia who are treated with similar medicines may have an increased risk of stroke or death (see section 4, Possible side effects).

• if you have Parkinson's disease or dementia.

• if you have ever been diagnosed with a condition characterized by high temperature and muscle rigidity (also known as Neuroleptic Malignant Syndrome).

• if you have ever experienced abnormal movements of the tongue or face (Tardive Dyskinesia).

You should be aware that these two disorders may be caused by this type of medicine.

• if you have previously had low levels of white blood cells in your blood (which may or may not have been caused by other medicines).
• if you have diabetes or are prone to diabetes.
• if you have heart disease or are being treated for heart conditions that could make you more susceptible to low blood pressure.
• if you have epilepsy.
• if you have swallowing difficulties or stomach or intestinal disorders that reduce your ability to swallow food or digest it with normal intestinal movements.
• if you have conditions associated with diarrhea.
• if you have kidney problems.
• if you have liver problems.
• if you experience a prolonged and/or painful erection.
• if you have difficulty regulating body temperature or feel overheated.
• if you have abnormally high levels of prolactin hormone in your blood or if you have a tumor that may be prolactin-dependent.
• if you or someone in your family has a history of blood clots, as antipsychotics have been associated with blood clot formation.

If you have any of these conditions, please consult your doctor, as you may require a dose adjustment or monitoring.

Because a dangerously low number of a type of white blood cells necessary to fight infections in the blood has been observed very rarely in patients treated with paliperidone, your doctor may check your white blood cell count.

Paliperidone may cause weight gain. Significant weight gain may negatively affect your health. Your doctor will regularly monitor your weight.

Cases of diabetes mellitus or worsening of pre-existing diabetes mellitus have been observed in patients treated with paliperidone. Your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be monitored regularly.

During eye surgery for lens clouding (cataracts), the pupil (the black circle in the center of the eye) may fail to dilate as needed. In addition, the iris (the colored part of the eye) may become flaccid during surgery, which could cause eye damage. If you are considering eye surgery, make sure to inform your ophthalmologist that you are taking this medicine.

Children and adolescents

Paliperidone must not be given to children and adolescents under 15 years of age for the treatment of schizophrenia.

Paliperidone must not be given to children and adolescents under 18 years of age for the treatment of schizoaffective disorder.

This is because it is unknown whether paliperidone is safe or effective in this age group.

Other medicines and paliperidone

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Abnormalities in the heart's electrical function may occur when this medicine is taken together with other medicines used to control heart rhythm or other medicines such as antihistamines, antimalarials, or antipsychotics.

Since this medicine acts mainly in the brain, it may interact with other medicines (or alcohol) that also act on the brain, due to additive effects on brain function.

This medicine may lower blood pressure, so caution is advised if you are taking it together with other medicines that also lower blood pressure.

This medicine may reduce the effectiveness of medicines used for Parkinson's disease and restless legs syndrome (e.g., levodopa).

The effects of this medicine may be altered if taken with medicines that influence intestinal motility (e.g., metoclopramide).

Dose reduction of this medicine should be considered when administered concomitantly with valproate.

The use of oral risperidone together with this medicine is not recommended, as this combination may lead to an increase in adverse effects.

Taking paliperidone with alcohol

You should avoid consuming alcohol during treatment with this medicine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before taking this medicine.

You should not take this medicine during pregnancy unless you have discussed it with your doctor.

The following symptoms may occur in newborn babies whose mothers were treated with paliperidone during the third trimester of pregnancy (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing difficulties, and feeding problems. If your baby develops any of these symptoms, you should contact your doctor.

You must not breastfeed while taking this medicine.

Driving and using machines

During treatment with this medicine, dizziness and vision problems (see section 4, Possible side effects) may occur. This should be taken into account when maximum attention is required, for example, when driving or operating machinery.

Warnings about excipients

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; essentially, it is "sodium-free".

3. How to take Inpalix

Follow exactly the instructions for using this medicine as given by your doctor. If in doubt, consult your doctor, pharmacist, or nurse.

Use in adults

The recommended dose for adults is 6 mg once daily in the morning. Your doctor may increase or decrease your dose within the dosage range of 3 mg to 12 mg once daily in the case of schizophrenia, or 6 mg to 12 mg once daily in the case of schizoaffective disorder. This depends on how well the medicine works for you.

Use in adolescents

The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years and older is 3 mg once daily taken in the morning.

For adolescents weighing 51 kg or more, the dose may be increased within the range of 6 mg to 12 mg once daily.

For adolescents weighing less than 51 kg, the dose may be increased to 6 mg once daily.

Your doctor will decide how much to give you. The dose you take depends on how well the medicine works for you.

How and when to take paliperidone

This medicine should be taken by mouth, swallowed whole with water or other liquids. It must not be chewed, broken, or crushed.

This medicine should be taken in the morning with breakfast or on an empty stomach, but always in the same way each day. Do not alternate between taking the medicine one day with breakfast and the next day on an empty stomach.

The active substance, paliperidone, dissolves after swallowing, and the tablet coating is eliminated from the body through the faeces.

Patients with kidney problems

Your doctor may adjust the dose of this medicine according to your kidney function.

Elderly patients

Your doctor may reduce your dose if your kidney function is reduced.

If you take more paliperidone than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist or go immediately to the nearest hospital, or call the Toxicology Information Service. Telephone: 91 562 04 20, indicating the medicine and the amount ingested. You may experience drowsiness, fatigue, abnormal body movements, difficulty standing and walking, dizziness due to lowered blood pressure, and changes in heartbeat.

If you forget to take paliperidone

Do not take a double dose to make up for missed doses. If you forget a dose, take the next dose the following day. If you miss two or more doses, contact your doctor.

If you stop taking paliperidone

Do not stop taking this medicine, as you will lose the medicine's effects. You should not stop taking this medicine unless instructed by your doctor, as your symptoms may return.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Tell your doctor immediately if:

• You develop blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty breathing. If you notice any of these symptoms, seek medical advice immediately.
• You have dementia and experience a sudden change in your mental state or sudden weakness or numbness of the face, arms, or legs—especially on one side—or have difficulty speaking, even for a short period of time. These may be signs of a stroke.
• You develop fever, muscle stiffness, sweating, or decreased level of consciousness (a disorder known as "Neuroleptic Malignant Syndrome"). Immediate medical treatment may be required.
• You are male and experience a prolonged or painful erection. This is known as priapism. Immediate medical treatment may be needed.
• You develop involuntary rhythmic movements of the tongue, mouth, or face. Discontinuation of paliperidone may be necessary.
• You experience a severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, skin rash, and sometimes a drop in blood pressure (i.e., an "anaphylactic reaction").

Very common: may affect more than 1 in 10 patients

• Difficulty falling or staying asleep
• Parkinsonism: This condition may include slow or altered movement, a sensation of muscle stiffness or tightness (causing jerky movements), and sometimes a "freezing" sensation in movement that then restarts. Other signs of parkinsonism include slow walking with shuffling of the feet, resting tremor, increased saliva and/or drooling, and loss of facial expression
• Restlessness
• Feeling drowsy or less alert/awake
• Headache

Common: may affect up to 1 in 10 patients

• Chest infection (bronchitis), symptoms of a common cold, nasal infection, urinary tract infection, feeling as if you have the flu
• Weight gain, increased appetite, weight loss, decreased appetite
• Euphoria (mania), irritability, depression, anxiety
• Dystonia: A condition involving involuntary, slow, or sustained muscle contractions. Although any part of the body may be affected (and may lead to abnormal postures), dystonia frequently affects facial muscles, including abnormal eye, mouth, tongue, or jaw movements
• Dizziness
• Dyskinesia: A condition involving involuntary muscle movements, which may include repetitive, spasmodic, or twisting movements or spasms
• Tremor
• Blurred vision
• Conduction disturbances between the upper and lower chambers of the heart, abnormalities in the heart's electrical conduction, QT interval prolongation on the electrocardiogram, slow heartbeat, fast heartbeat
• Decreased blood pressure upon standing (as a result, some people taking paliperidone may feel weakness, dizziness, or loss of consciousness when standing up or sitting down suddenly), increased blood pressure
• Sore throat, cough, nasal congestion
• Abdominal pain or discomfort, vomiting, nausea, constipation, diarrhea, indigestion, dry mouth, toothache
• Increased liver transaminases in the blood
• Itching, skin rash
• Bone or muscle pain, back pain, joint pain
• Absence of menstrual periods
• Fever, weakness, fatigue (tiredness)

Uncommon: may affect up to 1 in 100 patients

• Pneumonia, respiratory tract infection, bladder infection, ear infection, tonsillitis
• Decreased number of white blood cells, decreased platelets (blood cells that help stop bleeding), anemia, decreased number of red blood cells
• Paliperidone may increase levels of a hormone called "prolactin" detectable in blood tests (which may or may not cause symptoms). When symptoms of elevated prolactin occur, they may include: (in men) breast swelling, difficulty achieving or maintaining erections or other sexual dysfunction; (in women) breast discomfort, milk secretion from the breasts, absence of menstrual periods, or other menstrual cycle problems
• Diabetes or worsening of diabetes, increased blood sugar, increased waist circumference, loss of appetite leading to malnutrition and decreased body weight, increased blood triglycerides (a type of fat)
• Sleep disorder, confusion, decreased sexual desire, inability to achieve orgasm, nervousness, nightmares
• Tardive dyskinesia (involuntary spasms or spasmodic movements of the face, tongue, or other body parts). Inform your doctor immediately if you experience involuntary rhythmic movements of the tongue, mouth, or face. Discontinuation of paliperidone may be necessary
• Seizures (epileptic fits), fainting, restlessness causing body movements, dizziness upon standing, difficulty concentrating, speech problems, loss or changes in taste, decreased skin sensitivity to pain or touch, tingling, prickling, or numbness of the skin
• Eye sensitivity to light, eye infection, or "red eye," dry eyes
• Sensation of spinning (vertigo), ringing in the ears, ear pain
• Irregular heartbeat, abnormal electrical activity of the heart (electrocardiogram or ECG), sensation of fluttering or pounding in the chest (palpitations)
• Decreased blood pressure
• Difficulty breathing, wheezing (whistling in the chest), nosebleeds
• Swelling of the tongue, stomach or intestinal infection, difficulty swallowing, excess gas or flatulence
• Increased GGT (a liver enzyme called gamma-glutamyltransferase) in blood, increased liver enzymes in blood
• Hives (or "urticaria"), hair loss, eczema, acne
• Increased CPK (creatine phosphokinase) in blood, an enzyme sometimes released during muscle breakdown, muscle spasms, joint stiffness, joint swelling, muscle weakness, neck pain
• Urinary incontinence (loss of bladder control), frequent urination, inability to pass urine, pain during urination
• Erectile dysfunction, ejaculation disorder
• Absence of menstrual periods or other cycle problems (in women), milk secretion from the breasts, sexual dysfunction, breast pain, breast discomfort
• Swelling of the face, mouth, eyes, or lips, body swelling, arms or legs swelling
• Chills, increased body temperature
• Change in walking pattern
• Feeling of thirst
• Chest pain, chest discomfort, feeling of uneasiness
• Falls

Rare: may affect up to 1 in 1,000 patients

• Eye infection, fungal nail infection, skin infection, skin inflammation caused by mites
• Dangerously low number of a type of white blood cells needed to fight infections
• Decreased number of a type of white blood cells that help fight infections, increased eosinophils (a type of white blood cell) in blood
• Severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, skin rash, and sometimes drop in blood pressure; allergic reaction
• Sugar in urine
• Inappropriate secretion of a hormone that controls urine volume
• Life-threatening complications of uncontrolled diabetes
• Excessively dangerous water intake, low blood sugar, excessive water intake, increased blood cholesterol
• Sleepwalking
• Absence of emotions
• Neuroleptic Malignant Syndrome (confusion, decreased or loss of consciousness, high fever, and severe muscle stiffness)
• Loss of consciousness, balance disorder, abnormal coordination
• Problems in the blood vessels of the brain, coma due to uncontrolled diabetes, unresponsiveness to stimuli, decreased level of consciousness, head tremor
• Glaucoma (increased pressure in the eyeball), increased tearing, eye redness, eye movement problems, eye rolling
• Atrial fibrillation (abnormal heart rhythm), fast heartbeat upon standing
• Blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which may travel through blood vessels to the lungs causing chest pain and breathing difficulties. If you experience any of these symptoms, seek medical help immediately
• Decreased oxygen in parts of the body (due to reduced blood flow), flushing
• Breathing problems during sleep (sleep apnea), rapid, shallow breathing
• Aspiration pneumonia (caused by inhaling food), respiratory congestion, voice disorder
• Intestinal obstruction, fecal incontin游戏副本

5. Storage of Inpalix

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage temperature. Store in the original packaging to protect from moisture.

Do not use this medicine after the expiry date stated on the blister and the carton after EXP. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater drains or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of medicines and containers you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Inpalix

• The active substance is paliperidone. Each prolonged-release tablet contains 3 mg of paliperidone.

• The other components are:

• Tablet core: macrogol, butylated hydroxytoluene (E321), povidone, sodium chloride, microcrystalline cellulose, magnesium stearate, and iron oxide red (E172).

• Intermediate coated tablets: hydroxypropylcellulose.

• Semi-permeable coating: cellulose acetate and macrogol.

• Coating: hypromellose, titanium dioxide (E170), talc, and propylene glycol.

• Printing ink: shellac, iron oxide black (E172), and propylene glycol.

Appearance of the product and contents of the pack

Prolonged-release, round, biconvex tablets, white to greyish white in colour, marked with "P3" on one side.

Supplied in aluminium (oPA/Al/PVC)/aluminium blisters, in packs of 28 tablets.

Marketing Authorization Holder

Kern Pharma, S.L.

Venus, 72 – Pol. Ind. Colón II

08228 Terrassa – Barcelona

Spain

Manufacturer

Krka, d.d., Novo mesto

Šmarješka cesta 6

8501 Novo mesto

Slovenia

Date of the most recent revision of this summary: July 2018.

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/